CAPPED BONUSZERTIFIKAT - STRYKER CORP. Stock

Certificat

DE000PC5RUF8

Market Closed - Boerse Frankfurt Warrants 03:40:11 2024-05-10 pm EDT
292.6 EUR +0.09% Intraday chart for CAPPED BONUSZERTIFIKAT - STRYKER CORP.
Current month-1.14%
1 month-2.47%

Comparison chart between the derivative product and it's underlying value

End-of-day quotes
Date Price Change Volume
24-05-10 292.5 +0.06% 0
24-05-09 292.3 +0.36% 0
24-05-08 291.2 -0.88% 0
24-05-07 293.8 +1.61% 0
24-05-06 289.2 -0.31% 0

Real-time Boerse Frankfurt Warrants

Last update May 10, 2024 at 03:40 pm EDT

More quotes

Static data

Product typeCertificados de Bonus y Protección Parcial
Buy / SellCALL
Underlying STRYKER CORPORATION
IssuerLogo Issuer BNP Paribas BNP Paribas
WKN PC5RUF
ISINDE000PC5RUF8
Date issued 2024-02-27
Strike 400 $
Maturity 2025-12-19 (587 Days)
Parity 1 : 1
Emission price 294.9
Emission volume N/A
Settlement Por diferencias
Currency EUR

Technical Indicators

Highest since issue 304.4
Lowest since issue 287.6
Spread 0.5
Spread %0.17%

Company Profile

Stryker Corporation is one of the world's leaders in designing, manufacturing, and selling orthopedic equipments. Net sales break down by family of products as follows: - surgical equipments and neurotechnology products (57.5%): electric motorized surgical instruments, surgical navigation systems, endoscopy equipment, digital imaging systems, neurosurgery equipments, neurovascular devices, etc. The group also offers hospital beds, gurneys, stretchers, and emergency room equipment; - orthopedic implants (42.5%): joint prostheses, traumatology implants, micro-implants, orthopedic cement, orthobiology products, etc. The group also provides spinal implants. At the end of 2022, the group had 48 production sites worldwide. Net sales are distributed geographically as follows: the United States (73.9%), Europe/Middle East/Africa (12.7%), Asia/Pacific (10.2%) and other (3.2%).
Sector
-
More about the company

Ratings for Stryker Corporation

Trading Rating
Investor Rating
ESG Refinitiv
A-
More Ratings

Consensus: Stryker Corporation

Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
29
Last Close Price
330.6 USD
Average target price
372.4 USD
Spread / Average Target
+12.64%
Consensus
-40% Limited Time Offer: Our subscriptions help you unlock hidden opportunities.
SIGN UP NOW